Literature DB >> 18770077

Hallucinogen use disorders among adult users of MDMA and other hallucinogens.

Li-Tzy Wu1, Christopher L Ringwalt, Paolo Mannelli, Ashwin A Patkar.   

Abstract

We investigated the prevalence, patterns, and correlates of past-year DSM-IV hallucinogen use disorders (HUDs) among past-year users of MDMA and other hallucinogens from a sample of Americans 18 or older (n = 37,227). Users were categorized as MDMA users and other hallucinogen users. Overall, one in five (20%) MDMA users and about one in six (16%) other hallucinogen users reported at least one clinical feature of HUDs. Among MDMA users, prevalence of hallucinogen abuse, subthreshold dependence, and dependence was 4.9%, 11.9%, and 3.6%, respectively. The majority with hallucinogen abuse displayed subthreshold dependence. Most with hallucinogen dependence exhibited abuse. Subthreshold hallucinogen dependence is relatively prevalent and represents a clinically important subgroup that warrants future research and consideration in a major diagnostic classification system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18770077      PMCID: PMC2648386          DOI: 10.1080/10550490802269064

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  44 in total

1.  Co-occurring DSM-IV drug abuse in DSM-IV drug dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Deborah S Hasin; Mark Hatzenbueler; Sharon Smith; Bridget F Grant
Journal:  Drug Alcohol Depend       Date:  2005-04-18       Impact factor: 4.492

Review 2.  Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V?

Authors:  John E Helzer; Wim van den Brink; Sarah E Guth
Journal:  Addiction       Date:  2006-09       Impact factor: 6.526

3.  Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology.

Authors:  C F Turner; L Ku; S M Rogers; L D Lindberg; J H Pleck; F L Sonenstein
Journal:  Science       Date:  1998-05-08       Impact factor: 47.728

4.  Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.

Authors:  K Soar; J J D Turner; A C Parrott
Journal:  J Psychopharmacol       Date:  2006-05       Impact factor: 4.153

5.  Ecstasy abuse in Ireland.

Authors:  M T Cregg; J A Tracey
Journal:  Ir Med J       Date:  1993 Jul-Aug

6.  Drug use and HIV risk-taking behaviour among injecting drug users not currently in treatment in Sydney, Australia.

Authors:  A Baker; N Kochan; J Dixon; A Wodak; N Heather
Journal:  Drug Alcohol Depend       Date:  1994-01       Impact factor: 4.492

7.  Correlates of ecstasy use among students surveyed through the 1997 College Alcohol Study.

Authors:  George S Yacoubian
Journal:  J Drug Educ       Date:  2003

8.  Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.

Authors:  Li-Tzy Wu; William E Schlenger; Deborah M Galvin
Journal:  Drug Alcohol Depend       Date:  2006-02-17       Impact factor: 4.492

9.  The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence.

Authors:  Saul Shiffman; Andrew Waters; Mary Hickcox
Journal:  Nicotine Tob Res       Date:  2004-04       Impact factor: 4.244

10.  Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002.

Authors:  F Schifano; A Oyefeso; J Corkery; K Cobain; R Jambert-Gray; G Martinotti; A H Ghodse
Journal:  Hum Psychopharmacol       Date:  2003-10       Impact factor: 1.672

View more
  8 in total

1.  The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption.

Authors:  Alan K Davis; Joseph P Barsuglia; Rafael Lancelotta; Robert M Grant; Elise Renn
Journal:  J Psychopharmacol       Date:  2018-04-30       Impact factor: 4.153

2.  Alcohol and drug use disorders among adults in emergency department settings in the United States.

Authors:  Li-Tzy Wu; Marvin S Swartz; Zunyou Wu; Paolo Mannelli; Chongming Yang; Dan G Blazer
Journal:  Ann Emerg Med       Date:  2012-03-15       Impact factor: 5.721

3.  A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Jeng-Jong Pan; Bryce B Reeve; Dan G Blazer
Journal:  Int J Methods Psychiatr Res       Date:  2012-02-20       Impact factor: 4.035

4.  The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions.

Authors:  Li-Tzy Wu; Andy C Parrott; Christopher L Ringwalt; Chongming Yang; Dan G Blazer
Journal:  Am J Addict       Date:  2009 Nov-Dec

5.  An item response theory analysis of DSM-IV criteria for hallucinogen abuse and dependence in adolescents.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Chongming Yang; Bryce B Reeve; Dan G Blazer
Journal:  Addict Behav       Date:  2009-10-22       Impact factor: 3.913

6.  Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.

Authors:  Li-Tzy Wu; Christopher L Ringwalt; Roger D Weiss; Dan G Blazer
Journal:  Drug Alcohol Depend       Date:  2009-06-04       Impact factor: 4.492

7.  The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.

Authors:  Li-Tzy Wu; Andy C Parrott; Christopher L Ringwalt; Ashwin A Patkar; Paolo Mannelli; Dan G Blazer
Journal:  Addict Behav       Date:  2009-04-01       Impact factor: 3.913

8.  Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Jih-Heng Li; Dan G Blazer
Journal:  Subst Abuse Rehabil       Date:  2011-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.